Windhover.com | Medtech Insight | The RPM Report | Inteleos | EBI
Subscriber Username:   Password: Forgot Password?
Health Care Business Intelligence, Analysis, Insight - Windhover
Search


Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight


Sign up now


Providing unparalleled analysis and insight of the deals and products
shaping the Health Care industry.


Subscriber Login

Strategic Transactions delivers the most comprehensive deals data in the industry, including alliances, financings and M&As across biopharmaceuticals, devices, diagnostics and tech transfers. Better yet, it’s the only database with available, hyperlinked analysis from our award-winning editorial staff.

You'll receive:

  • More than 24,000 deals from 1991 to the present
  • Summaries of company, product and financial information, plus SEC & contract filings
  • Simple and sophisticated search that’s fully exportable
  • Extensive cross-linking of deals, companies and commentary
  • Regular e-newsletter includes new and updated deals
  • Thoroughly fact-checked by a dedicated team of analysts

Benchmark competitors, evaluate comparable deals, gather authoritative data for negotiations, and profile potential partners with Strategic Transactions. Learn more!

Inteleos offers the in-depth drug information you need to fully understand the value of a deal for a particular drug and be confident in your dealmaking decisions.
Upgrade your Strategic Transactions subscription to include the latest product pipeline data from Inteleos. Learn more.

Subscriber Login

Inteleos features comprehensive data on more than 10,000 drugs and biologics, complete with in-depth regulatory coverage, detailed development timelines and competitor profiles. Inteleos is the premier business intelligence tool and offers intuitive indexing and search capabilities with flexible export options to fulfill your drug development research needs.

You'll receive:

  • Track biologic and drug development from preclinical through approval and post-marketing studies
  • Find information about new partners and stay up to date on competitor's activities
  • In depth regulatory submission and approval filings with industry, conference and regulatory news from leading Elsevier sources
  • Detailed clinical trial info
  • Graphically dynamic analysis tools to view content from different perspectives
  • Personalized alerts on content updates relevant to your portfolio

Inteleos is the most intuitive, flexible tool for drug pipeline, research, tracking and analysis. Learn more!


Subscriber Login

Transaction Tracker is a snapshot of current pharmaceutical dealmaking activity, featuring the most recent two months of data plus analysis of the latest trends. It’s the most popular features of Strategic Transactions at an affordable price!

You'll receive:

  • Dealmaking activity: A complete picture of the most recent two months of transactions
  • Dedicated homepage: A homepage exclusively for Transaction Tracker subscribers that’s user-friendly and convenient
  • Deal updates: Continual updates of earlier deals
  • FREE weekly email: An available, FREE weekly email newsletter to alert you to the hottest new activity
  • Analysis & commentary: Selected trend analysis from our dedicated editorial team
  • Profiles: In-depth profiles of all deal-active companies

Transaction Tracker is designed to help you stay on top of the fast-moving dealmaking landscape and identify risks and opportunities for your business across the industry. Learn more!


To request further information on the Elsevier Business Intelligence suite of database products, please contact James DeFalco at (203) 838-4401 ext: 104 or via email at: j.defalco@elsevier.com

The IN VIVO Blog

Pharmaceutical Strategic Alliances
September 21-23, 2010 · New York, NY

PharmAsia Summit
October 25-26, 2010 · San Francisco, CA

IN3 Summit
October 27-29, 2010 · San Francisco, CA

Interested in presenting at a Windhover conference?
Submit your idea here


Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Novartis is mirroring its approach to pharma R&D and leveraging the byproducts of its biomarker work there to build a commercial molecular diagnostics franchise. The head of the unit talks about its structure, strategy and programs. . . [MORE] (IN VIVO)

Bioactive Technologies For Bone Replacement
Expanded indications for bone morphogenetic proteins and new alternatives to those first-generation bone growth factors have the potential to grow the $2 billion market for bone replacement materials. . . [MORE] (Start-Up)

Laser Cataract Surgery Comes into Focus at ASCRS
The mood was primarily upbeat at April's annual meeting of the American Society of Cataract and Refractive Surgery. Most in attendance expected a modest rebound in procedure volumes for 2010. . . [MORE] (Medtech Insight)

FDA, Drug Development and Health Care Reform: A Panel Discussion
Current and former FDA officials and a former Big Pharma head of R&D discuss FDA and the relationship between a regulator and the industry it regulates when it comes to drug development. . . [MORE] (The RPM Report)

Read more from the latest: IN VIVO, Start-Up, The RPM Report, Medtech Insight, "The Pink Sheet", "The Pink Sheet" DAILY, "The Rose Sheet", "The Tan Sheet", PharmAsia News, Pharmaceutical Approvals Monthly, and "The Gray Sheet".




Pharma Deals
  FDA Has Full Plate This Fall for Vaccines: More Than H1N1
  GSK Slides Away From Innovation
  The Billion Dollar REMS: Xenazine?
Device Deals
  Stroke Devices: Facing Challenges Head On
  Vascular Closure Devices at the Crossroads
  What New Her2 Tests Say about Personalized Medicine

Interested in subscribing? Click here.
Publications - Databases - Conferences - Webinars - About Us - Contact Us - Help - The IN VIVO Blog - RSS Feeds - Company Profiles - Subscriber Login

Copyright © 2010, Windhover Information, Inc. An Elsevier company. All rights reserved.

Elsevier Business Intelligence